SB Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,886,107
| Closed | -$17.2M | – | 4 |
|
|
2022
Q1 | $17.2M | Sell |
1,886,107
-6,270,000
| -77% | -$57.1M | 3.33% | 9 |
|
|
2021
Q4 | $167M | Hold |
8,156,107
| – | – | 16.5% | 2 |
|
|
2021
Q3 | $208M | Sell |
8,156,107
-1,704,982
| -17% | -$43.6M | 21.35% | 1 |
|
|
2021
Q2 | $345M | Hold |
9,861,089
| – | – | 4.05% | 4 |
|
|
2021
Q1 | $328M | Buy |
9,861,089
+669,334
| +7% | +$22.3M | 2.12% | 9 |
|
|
2020
Q4 | $238M | Buy |
+9,191,755
| New | +$238M | 1.35% | 10 |
|